research reports and media, page-4153

@Mozzarc


In terms of upward SP, i agree that acceptance into the TGA program would be a significant positive, but i don't expect PAR to move on that until they are sorted on the next step with FDA. If FDA want more evidence, i think that will delay TGA entry, but maybe not depending what FDA ask for. We should know that soon.

What do you/others think?
On the other hand if responding to FDA still dragging on past August, PAR will have to do something or face another CR soon after. Actually, i don't think there are many hoops that FDA can come up with, just more on dosage and safety, which we can pass, but it will take time.

Which brings me back to how do we get enough new investors on board, -- US investors.
I think by now everyone knows what i think about that....

I only wish others would put some actual pressure on the board to do something useful which is SP positive, like
Sell MPS and get ADR type II. Oh i said it again, anyway,


IMO. DYOR..